MX2010006084A - Peptidos del factor viii y su uso en la tolerizacion de hemofilicos. - Google Patents

Peptidos del factor viii y su uso en la tolerizacion de hemofilicos.

Info

Publication number
MX2010006084A
MX2010006084A MX2010006084A MX2010006084A MX2010006084A MX 2010006084 A MX2010006084 A MX 2010006084A MX 2010006084 A MX2010006084 A MX 2010006084A MX 2010006084 A MX2010006084 A MX 2010006084A MX 2010006084 A MX2010006084 A MX 2010006084A
Authority
MX
Mexico
Prior art keywords
fviii peptides
peptide
peptides
tolerising
haemophiliacs
Prior art date
Application number
MX2010006084A
Other languages
English (en)
Spanish (es)
Inventor
David Wraith
Original Assignee
Apitope Technology Bristol Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Apitope Technology Bristol Ltd filed Critical Apitope Technology Bristol Ltd
Publication of MX2010006084A publication Critical patent/MX2010006084A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745Blood coagulation or fibrinolysis factors
    • C07K14/755Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36Blood coagulation or fibrinolysis factors
    • A61K38/37Factors VIII
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Transplantation (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MX2010006084A 2007-12-04 2008-12-03 Peptidos del factor viii y su uso en la tolerizacion de hemofilicos. MX2010006084A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0723712.6A GB0723712D0 (en) 2007-12-04 2007-12-04 Peptides
PCT/GB2008/003996 WO2009071886A1 (en) 2007-12-04 2008-12-03 Fviii peptides and their use in tolerising haemophiliacs

Publications (1)

Publication Number Publication Date
MX2010006084A true MX2010006084A (es) 2010-06-23

Family

ID=38982965

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010006084A MX2010006084A (es) 2007-12-04 2008-12-03 Peptidos del factor viii y su uso en la tolerizacion de hemofilicos.

Country Status (25)

Country Link
US (1) US8445448B2 (https=)
EP (1) EP2227488B3 (https=)
JP (2) JP5501245B2 (https=)
KR (1) KR101519840B1 (https=)
CN (2) CN101889024B (https=)
AU (1) AU2008332968B2 (https=)
BR (1) BRPI0820143A2 (https=)
CA (2) CA3005013C (https=)
CY (1) CY1115168T1 (https=)
DK (1) DK2227488T6 (https=)
EA (1) EA019370B1 (https=)
EC (1) ECSP10010327A (https=)
ES (1) ES2458315T7 (https=)
GB (1) GB0723712D0 (https=)
HR (1) HRP20140344T4 (https=)
IL (1) IL205780A (https=)
MX (1) MX2010006084A (https=)
MY (1) MY150995A (https=)
NZ (1) NZ585217A (https=)
PL (1) PL2227488T6 (https=)
PT (1) PT2227488E (https=)
SI (1) SI2227488T1 (https=)
UA (1) UA101003C2 (https=)
WO (1) WO2009071886A1 (https=)
ZA (1) ZA201002997B (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1731912T1 (sl) 2000-08-21 2014-05-30 Apitope Technology (Bristol) Limited Postopek izbire peptida
GB0801513D0 (en) * 2008-01-28 2008-03-05 Circassia Ltd Peptides from factor VIII
KR20160104740A (ko) * 2008-06-24 2016-09-05 옥타파마 아게 응고 인자 viii을 정제하는 방법
GB0908515D0 (en) * 2009-05-18 2009-06-24 Apitope Technology Bristol Ltd Peptide
SG176783A1 (en) * 2009-06-16 2012-01-30 Univ Tokai Anti-gram-negative bacteria agent
BR112013010362A2 (pt) * 2010-10-27 2016-08-02 Baxter Healthcare Sa métodos para induzir uma tolerância imune a fviii, para fazer um peptídeo fviii, e para identificar uma célula t específica de peptídeo fvii, peptídeo, composição, e, proteína de fusão
EP3970737A1 (en) 2012-01-12 2022-03-23 Bioverativ Therapeutics Inc. Reducing immunogenicity against factor viii in individuals undergoing factor viii therapy
RS56069B1 (sr) * 2012-11-12 2017-10-31 Apitope Int Nv Faktor viii-izvedenih peptida za upotrebu u lečenju hemofilije a
GB201314052D0 (en) * 2013-08-06 2013-09-18 Apitope Int Nv Peptides
CN108884140B (zh) 2015-12-03 2022-10-25 朱诺治疗学股份有限公司 修饰的嵌合受体及相关组合物和方法
CN110520149A (zh) 2016-12-02 2019-11-29 比奥维拉迪维治疗股份有限公司 诱导对凝血因子的免疫耐受性的方法
US12077607B2 (en) * 2021-09-23 2024-09-03 University Of Utah Research Foundation Functional and therapeutic effects of PAR4 cleavage by cathepsin G

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990015615A1 (en) 1989-06-20 1990-12-27 Scripps Clinic And Research Foundation The phospholipid binding domain of factor viii
BR9806793A (pt) * 1997-01-22 2000-05-16 Univ Texas Processos e composições de fator tissular para coagulação e tratamento de tumores.
SI1731912T1 (sl) * 2000-08-21 2014-05-30 Apitope Technology (Bristol) Limited Postopek izbire peptida
US20040096456A1 (en) * 2000-12-01 2004-05-20 Conti-Fine Bianca M Method to treat hemophilia
US7189830B2 (en) * 2001-02-19 2007-03-13 Merck Patent Gmbh Anti-KSA/IL-2 fusion proteins with reduced immunogenicity
AU2002312660A1 (en) 2001-05-31 2002-12-16 D. Collen Research Foundation Vzw Onderwijsen Navorsing Campus Gasthuisberg K.U. Leuven Recombinant molecules with reduced immunogenicity, methods and intermediates for obtaining them and their use in pharmaceutical compositions and diagnostic tools
JP2005538694A (ja) * 2002-04-18 2005-12-22 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング 修飾されたviii因子
ES2567634T3 (es) * 2004-02-09 2016-04-25 Human Genome Sciences, Inc. Proteínas de fusión de albúmina
WO2006003183A1 (de) 2004-07-02 2006-01-12 Alois Jungbauer Peptide zur blockierung von fviii-inhibitoren
IL229645A0 (en) * 2013-11-26 2014-03-31 Omrix Biopharmaceuticals Ltd A dry bandage containing thrombin and pectin

Also Published As

Publication number Publication date
ES2458315T3 (es) 2014-04-30
AU2008332968B2 (en) 2014-03-20
KR20100087346A (ko) 2010-08-04
JP5501245B2 (ja) 2014-05-21
EA019370B1 (ru) 2014-03-31
US8445448B2 (en) 2013-05-21
PT2227488E (pt) 2014-04-21
UA101003C2 (uk) 2013-02-25
EP2227488B1 (en) 2014-01-22
DK2227488T3 (da) 2014-04-22
IL205780A (en) 2015-06-30
EP2227488B3 (en) 2014-11-19
JP6063402B2 (ja) 2017-01-18
MY150995A (en) 2014-03-31
GB0723712D0 (en) 2008-01-16
CA3005013A1 (en) 2009-06-11
WO2009071886A1 (en) 2009-06-11
JP2011505414A (ja) 2011-02-24
HRP20140344T4 (hr) 2015-07-31
AU2008332968A1 (en) 2009-06-11
CA3005013C (en) 2021-11-16
EP2227488A1 (en) 2010-09-15
DK2227488T6 (en) 2015-02-16
US20100323966A1 (en) 2010-12-23
HRP20140344T1 (en) 2014-05-09
CN103709234B (zh) 2017-01-18
KR101519840B1 (ko) 2015-05-18
JP2014088440A (ja) 2014-05-15
ZA201002997B (en) 2011-07-27
ECSP10010327A (es) 2010-09-30
CN101889024B (zh) 2014-04-23
SI2227488T1 (sl) 2014-06-30
CN101889024A (zh) 2010-11-17
IL205780A0 (en) 2010-11-30
CY1115168T1 (el) 2016-12-14
PL2227488T6 (pl) 2015-04-30
CA2707559A1 (en) 2009-06-11
BRPI0820143A2 (pt) 2015-05-12
HK1144292A1 (en) 2011-02-11
EA201070681A1 (ru) 2010-10-29
NZ585217A (en) 2012-11-30
PL2227488T3 (pl) 2014-07-31
CA2707559C (en) 2018-07-03
CN103709234A (zh) 2014-04-09
ES2458315T7 (es) 2015-02-18

Similar Documents

Publication Publication Date Title
MX2010006084A (es) Peptidos del factor viii y su uso en la tolerizacion de hemofilicos.
EA201592264A1 (ru) Композиции, которые индуцируют хелперное действие т-клеток
UA103751C2 (ru) Иммуногенный пептид для иммунотерапии
NZ595707A (en) Cancer antigen helper peptide
WO2008121615A3 (en) Antibody formulation
IN2012DN03338A (https=)
UA100372C2 (ru) Выделенный пептид, способный индуцировать цитотоксические т-клетки, и его применение в качестве вакцины
WO2004081028A3 (en) Allergen peptide fragments and use thereof
PH12016500218A1 (en) Peptides
ATE552276T1 (de) Modifizierter anti-cd52-antikörper
IN2014CN04374A (https=)
ATE412671T1 (de) Modifizierter faktor viii
MY168207A (en) Fviii-derived peptides
EA201171001A1 (ru) Пептиды трав для вакцины
PH12015501033A1 (en) Peptides
IL184609A0 (en) Compositions containing an antigen and an adjuvent peptide
UA97092C2 (ru) T-клеточные эпитопы с раково-эмбрионального антиген-незрелого рецепторного белка ламинина и их медицинское применение
ZA200707970B (en) Compositions of HSP60 peptides and viral antigens for vaccination and diagnosis
WO2008150981A3 (en) Novel short peptides that inhibit the opening of mammalian tight junctions
WO2007097828A3 (en) Method for identifying and validating dominant t helper cell epitopes using an hla-dm-assisted class ii binding assay
WO2007071850A3 (fr) Inhibition de la réponse immunitaire anti-fviii
SI1485719T1 (sl) Peptidni epitopi, ki so skupni antigenom iste multigenske druĹľine

Legal Events

Date Code Title Description
GB Transfer or rights
FG Grant or registration